首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Macrophage activation syndrome: A diagnostic challenge (Review)
【2h】

Macrophage activation syndrome: A diagnostic challenge (Review)

机译:巨噬细胞激活综合征:诊断挑战(审查)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Macrophage activation syndrome (MAS) represents an acute and severe inflammatory syndrome, idiopathic (primary) or secondary to infections, rheumatic diseases, malignancies, or drugs. MAS is underdiagnosed, being confused with sepsis, adverse effects of anti-arthritic drugs or exacerbated symptoms of evolving rheumatologic or infectious diseases. Because of the late diagnosis, most patients do not benefit from effective therapy, leading to death. Elucidation of valid early diagnostic criteria of MAS would be a particularly important step in reducing the mortality due to this pathology. Thus, the purpose of this review based on 40 studies centered on the diagnostic criteria of MAS. We detailed the main diagnostic criteria and the few diagnostic scores or sets of criteria that have been recently published. The criteria most frequently encountered in the literature include: Fever, hepatosplenomegaly, hyperferritinemia, hepatopathy, coagulopathy, thrombocytopenia, hypertriglyceridemia, decrease in erythrocyte sedimentation rate and bone marrow hemophagocytosis. The most elaborate diagnostic score will result following an ongoing international project and consensus, the Delphi International Survey.
机译:巨噬细胞活化综合征(MAS)表示急性和严重的炎症综合征,特发性(主)或继发于感染,风湿性疾病,恶性肿瘤,或药物。 MAS被诊断,与败血症混淆,抗关节炎药物的不良反应或加剧了风湿病或传染病的恶化症状。由于诊断晚期,大多数患者不会受益于有效的治疗,导致死亡。阐明MAS的有效早期诊断标准将是降低由于这种病理学引起的死亡率的特别重要步骤。因此,基于40项研究的综述目的是以MAS的诊断标准为中心。我们详细介绍了最近发布的主要诊断标准和少数诊断分数或标准集。文献中最常遇到的标准包括:发烧,肝肺肿大,高温血症,肝病,凝血病,血小板减少,高甘油三酯血症,红细胞沉降率和骨髓血糖症的降低。最具精心制作的诊断得分将在持续的国际项目和共识之后导致德尔福国际调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号